Get the app!
Back to Trades
Other4

ENZO BIOCHEM INC

ENZB

Total Value
$0

Company Information

Company Name
ENZO BIOCHEM INC
Ticker Symbol
ENZB
CIK
0000316253

Insider Information

Role
Chief Financial Officer
Officer
Location
FARMINGDALE, NY

Filing Details

Filing Date
Aug 20, 2025
Transaction Date
Aug 20, 2025
Accession Number
0001213900-25-078740
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Aug 20, 2025Common Stock28,328Disposition

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Aug 20, 2025Derivative100,000Disposition
Aug 20, 2025Derivative75,000Disposition
Aug 20, 2025Derivative25,000Disposition
Aug 20, 2025Derivative50,000Disposition
Aug 20, 2025Derivative25,000Disposition

Footnotes

  1. (F1)The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
  2. (F2)Pursuant to the Merger Agreement, at the Effective Time, each option that was outstanding as of immediately prior to the Effective Time was automatically, and without any required action on the part of the Reporting Person, canceled without any cash payment or other consideration being made in respect thereof.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.